Analysis on Application of Antiplatelet Drugs on Patients with Cardiovascular Disease During Hospitalization in 10 Hospitals in Tianjin from 2017 to 2020
返回论文页
|更新时间:2022-10-08
|
Analysis on Application of Antiplatelet Drugs on Patients with Cardiovascular Disease During Hospitalization in 10 Hospitals in Tianjin from 2017 to 2020
HAN Yaoyao, DUAN Rong, LI Zhengxiang. Analysis on Application of Antiplatelet Drugs on Patients with Cardiovascular Disease During Hospitalization in 10 Hospitals in Tianjin from 2017 to 2020. [J]. 21(3):343-347(2021)
HAN Yaoyao, DUAN Rong, LI Zhengxiang. Analysis on Application of Antiplatelet Drugs on Patients with Cardiovascular Disease During Hospitalization in 10 Hospitals in Tianjin from 2017 to 2020. [J]. 21(3):343-347(2021) DOI: 10.14009/j.issn.1672-2124.2021.03.020.
Analysis on Application of Antiplatelet Drugs on Patients with Cardiovascular Disease During Hospitalization in 10 Hospitals in Tianjin from 2017 to 2020
OBJECTIVE: To investigate the application of antiplatelet drugs on patients with cardiovascular disease during hospitalization in Tianjin
so as to provide references for standardizing rational drug application.METHODS:Inpatients in department of cardiovascular in 10 hospitals in Tianjin from 2017 to 2020 were set as subjects
Epidata software was used to conduct data input
SPSS 26.0 was used for data collecting and analyzing.RESULTS: Totally1 178 patients were involved
of which 499 patients( 42.4%) with angina pectoris
158 patients( 13.4%) with acute myocardial infarction
390 patients( 33.1%) with coronary heart disease
131 patients( 11.1%) with other types of diseases; the selection rate of antiplatelet drugs from high to low were respectively aspirin
clopidogrel
ticagrelor
tirofiban and cilostazol; the administration route of loading dose combination were mainly with aspirin and clopidogrel
but the loading dose application rate was low; the administration route of maintenance dose combination were mainly with aspirin and clopidogrel; there were differences in the characteristics of the medication behavior of different diseases
while there were also inconsistencies in characteristics of the medication behavior of same disease.CONCLUSIONS: There are differences in the medication behavior of inpatients with cardiovascular diseases in Tianjin in the drug selection
loading dose
maintenance dose and drug combination of antiplatelet drugs
the scientific and standardized treatment strategy still needs to be confirmed by large sample of real-world studies.